Dynacare is committed to aligning test offerings with current guidelines and recommendations to support timely, cost-effective, quality patient care. Effective September 26th, 2022, Dynacare will discontinue offering IgM testing for Herpes Simplex Virus (HSV) for Types 1 and 2.
Read More - Discontinuation of Herpes Simplex Virus (HSV) Testing - Ontario and Quebec